Even trace contaminants can compromise the safety, performance, and approval of a biomedical device. Identifying and quantifying impurities is essential to maintain product integrity, prevent recalls, and satisfy ISO and FDA standards. Invision Biomedical provides advanced contaminant and impurity analysis to safeguard your devices from hidden risks.
Sensitive imaging and chemical analysis detect microscopic particles before they reach patients.
Advanced methods identify trace compounds across multiple chemical classes, ensuring materials are pure.
Testing helps determine contamination sources, from raw materials to manufacturing environments.
Data packages are aligned with ISO and FDA expectations, minimizing regulatory setbacks.
They can cause irritation, toxic reactions, or long-term health risks, making their elimination essential.
